Asad Abbas | Natural and plant-based skincare ingredients | Best Researcher Award

Posted on by Skincare

Best Researcher Award

Asad Abbas
Multan College of Nutrition, Pakistan

Affiliation Multan College of Nutrition
Country Pakistan
Documents 38
Citations 281
h-index 6
Subject Area Natural and plant-based skincare ingredients
Event World Skincare Innovation Awards
ORCID 0000-0002-7154-3411

Asad Abbas is a researcher affiliated with Multan College of Nutrition, Pakistan, whose academic work focuses on natural and plant-based skincare ingredients. His research interests include the evaluation of bioactive compounds, nutritional approaches, and naturally derived materials relevant to skin health and cosmetic science. His scholarly contributions are reflected through published research documents, citation records, and scientific engagement in the field of natural skincare research. [1]

Abstract

Natural and plant-derived ingredients have become significant areas of investigation within skincare science due to their potential antioxidant, anti-inflammatory, antimicrobial, and skin-supportive properties. Asad Abbas has contributed to research exploring the relationship between bioactive natural compounds and their applications in skincare and health-related fields. His academic profile demonstrates continued engagement with research involving naturally sourced ingredients and their scientific evaluation. [2]

Keywords

  • Plant-based skincare
  • Natural bioactive compounds
  • Cosmetic science
  • Antioxidants
  • Skin health research

Introduction

The growing demand for sustainable and scientifically validated skincare solutions has increased research interest in plant-derived compounds. These compounds are investigated for their biological activities and possible roles in supporting skin protection, repair mechanisms, and cosmetic formulation development. Researchers working in this field contribute to understanding the mechanisms through which natural materials interact with skin biology. [3]

Research Profile

Asad Abbas has developed a research profile associated with natural and nutritional sciences, particularly focusing on areas connected with plant-based skincare ingredients. According to available academic profile information, his scholarly record includes 38 research documents with 281 citations and an h-index of 6, indicating measurable academic contribution and research visibility. [1]

Research Contributions

The research contributions of Asad Abbas involve investigations into naturally occurring compounds and their relevance to health and skincare applications. Such research supports the broader scientific understanding of functional ingredients, bioactive molecules, and evidence-based approaches in cosmetic and dermatological research.

  • Evaluation of natural ingredients with potential skincare applications.
  • Research on bioactive compounds associated with skin health.
  • Contribution to scientific literature in nutrition and cosmetic-related research areas.

Publications

The publication record of Asad Abbas includes scientific documents related to nutrition, natural compounds, and related biomedical research areas. His publications contribute to ongoing discussions regarding the scientific evaluation of plant-derived materials and their possible applications in human health and skincare innovation. [1]

Research Impact

Research impact can be evaluated through indicators such as publication output, citation performance, and scholarly indexing metrics. Asad Abbas has demonstrated academic influence through citation activity and continued contribution to research areas associated with natural ingredients and skincare science. [1]

Award Suitability

The Best Researcher Award recognition under the World Skincare Innovation Awards acknowledges researchers contributing to scientific advancement in skincare-related disciplines. Based on his academic profile, research documents, citation record, and focus on natural and plant-based skincare ingredients, Asad Abbas represents a researcher working within an area aligned with contemporary skincare innovation research. [4]

Conclusion

Asad Abbas has established a research profile focused on natural and plant-based skincare ingredients, contributing to scientific discussions surrounding bioactive compounds and their potential applications. His publication record, citation indicators, and research interests demonstrate continued involvement in academic research related to skincare innovation and natural product science.

References

  1. Elsevier. (n.d.). Google Scholar author details: Asad Abbas, Author ID H7G1IrAAAAAJ. Google Scholar.
    https://scholar.google.com/citations?user=H7G1IrAAAAAJ&hl=en
  2. Carvalho, A. F. U., et al. (2022). Bioactive compounds from natural sources and their potential applications in health sciences. Molecules.
    https://doi.org/10.3390/molecules27092912
  3. World Skincare Innovation Awards. (n.d.). Research Recognition and Award Platform.
    https://skincareaward.com/
  4. National Library of Medicine. (n.d.). Scientific literature database resources for biomedical research.
    https://pubmed.ncbi.nlm.nih.gov/

Dilek Kaan | Stem Cell | Best Researcher Award

Posted on by Skincare

Best Researcher Award

Dilek Kaan
Affiliation Erciyes University
Country Turkey
Scopus ID 57189595553
Documents 4
Citations 48
h-index 2
Subject Area Stem Cell
Event World Skincare Innovation Awards
ORCID 0000-0003-3622-2249

Dilek Kaan
Erciyes University

Dilek Kaan is a researcher associated with Erciyes University whose scholarly work has focused primarily on stem cell studies, cellular biology, extracellular vesicles, and molecular investigations related to disease mechanisms. Research records indexed through ORCID and Scopus indicate contributions within laboratory and translational biomedical studies that explore cellular behavior and experimental biological systems.[1]

Abstract

This article summarizes academic activities, publication records, and research characteristics associated with Dilek Kaan. Available indexed records indicate involvement in studies related to stem cell biology and molecular investigations, including extracellular vesicles and cellular signaling mechanisms. The article also presents publication references and research indicators relevant to academic recognition assessment.[2]

Keywords

Stem cell biology, extracellular vesicles, apoptosis, molecular biology, translational medicine, biomedical research, cellular mechanisms.

Introduction

Biomedical research increasingly depends on molecular approaches that clarify mechanisms of disease and cellular regulation. Investigations involving stem cells and associated biological pathways support the development of translational understanding in medicine. Published work associated with Dilek Kaan reflects participation in this broader scientific environment.[3]

Research Profile

Research activities associated with Dilek Kaan reflect interdisciplinary work in molecular biology, stem cell science, and experimental biomedical research. Available indexed author records indicate continuing involvement in studies related to cellular mechanisms and laboratory-based scientific investigations. Research efforts have focused on understanding biological pathways and molecular responses associated with disease conditions and experimental models. The profile also demonstrates participation in research themes that integrate translational and cellular perspectives within modern biomedical sciences.[4]

Research Contributions

Research contributions include studies involving stem cell lines, extracellular vesicles, apoptosis mechanisms, and molecular biomarker analysis. Published findings contribute toward understanding cellular responses and biological interactions observed under different experimental conditions. Research outcomes may support future investigations involving translational medicine and laboratory applications. These activities collectively indicate a continuing contribution toward biomedical and molecular research development.[5]

Publications

Published work associated with Dilek Kaan includes investigations related to mesenchymal stem cell exosomes, molecular biology, extracellular vesicle isolation, and disease-associated cellular processes. Several studies evaluate biological responses and experimental cellular mechanisms within laboratory environments. Publication records also indicate research on gene expression and apoptosis pathways. These studies collectively reflect consistency in scientific themes across multiple biomedical contexts.[1]

Research Impact

Citation indicators and indexed publication activity provide measurable information regarding scholarly dissemination and academic visibility. Bibliometric indicators are frequently used as supporting measures when evaluating scientific engagement and research reach. Research influence is commonly interpreted together with publication quality and collaboration activity. Such indicators contribute to understanding the broader academic significance of published scientific work.

Award Suitability

Evaluation for research recognition generally considers publication quality, research consistency, scholarly productivity, and scientific contributions. Available publication records and indexed research metrics indicate continuing participation within biomedical investigations. Research themes associated with stem cell science and molecular studies align with current scientific interests. These characteristics may support consideration within academic recognition frameworks.

Conclusion

Academic profiles integrate publication history, collaborative work, and scientific output into a broader perspective of scholarly activity. Available records associated with Dilek Kaan indicate continuing research engagement involving molecular biology and stem cell investigations. Publication themes demonstrate consistency across experimental biomedical studies and laboratory-based research environments. The profile therefore reflects an active contribution within contemporary scientific research areas.

References

  1. Kaan, D. (2022). Expression and biochemical significance of Piwil2 in stem cell lines. Postępy Higieny i Medycyny Doświadczalnej.
    https://doi.org/10.2478/ahem-2022-0009
  2. Kaan, D. (2023). Adipoz Doku Kaynaklı Ekstrasellüler Veziküllerin Meme Kanseri Hücreleri Üzerine Apoptotik Etkisi. Iğdır Üniversitesi Fen Bilimleri Enstitüsü Dergisi.
    https://doi.org/10.21597/jist.1213841
  3. Kaan, D. (2023). Wharton Jel Kaynaklı Eksozom İzolasyonu: Metot Karşılaştırma Çalışması. Iğdır Üniversitesi Fen Bilimleri Enstitüsü Dergisi.
    https://doi.org/10.21597/jist.1200996
  4. Şengül, A., Kaan, D., & Güler, H. (2026). Evaluation of Individual Effects of Melatonin and Mesenchymal Stem Cell Exosomes. Current Issues in Molecular Biology.
    https://doi.org/10.3390/cimb48060623
  5. Eciroglu, H., Şener, E.F., Öztop, D.B., Özmen, S., Kaan, D., & Özkul, Y. (2022). The relationship of learning and memory dysfunction with NEURL1 and RGS14 genes in autism spectrum disorders. Acta Medica Alanya.
    https://doi.org/10.30565/medalanya.1136820

Abraham Getachew Kelbore | Deramtology | Innovative Research Award

Posted on by Skincare

Innovative Research Award

Abraham Getachew Kelbore – Wolaita Sodo University

Abraham Getachew Kelbore
Affiliation Wolaita Sodo University
Country Ethiopia
Scopus ID 56798540800
Documents 3024
Citations 3072
h-index 12
Subject Area Dermatology
Event World Skincare Innovation Awards
ORCID 0000-0001-9540-8671

Abraham Getachew Kelbore is an academic researcher and assistant professor specializing in tropical dermatology at Wolaita Sodo University, Ethiopia. His scholarly work focuses on skin diseases, neglected tropical diseases, and quality-of-life studies among dermatology patients. Through clinical research and community engagement, he has contributed to improving dermatological care in underserved regions. His research profile demonstrates active international collaboration and sustained scientific productivity.[1]

Abstract

This article summarizes the scholarly achievements of Abraham Getachew Kelbore in dermatology and tropical medicine. His research emphasizes evidence-based interventions, epidemiology of skin diseases, and healthcare accessibility in Ethiopia. The body of work demonstrates multidisciplinary collaboration and international visibility in peer-reviewed literature. These contributions support recognition within global dermatological research communities.[2]

Keywords

Dermatology, Tropical Medicine, Atopic Dermatitis, Skin Diseases, Ethiopia, Public Health, Neglected Tropical Diseases.

Introduction

Research in dermatology contributes significantly to disease prevention and quality-of-life improvement. Abraham Getachew Kelbore has focused on tropical skin disorders and healthcare delivery in resource-limited settings. His work bridges clinical practice, research, and community health initiatives. Such contributions align with broader public health priorities in Africa and beyond.[3]

Research Profile

Kelbore serves as Assistant Professor of Dermatology at Wolaita Sodo University and has extensive teaching experience. His interests include atopic dermatitis, neglected tropical diseases, and dermatological epidemiology. He has collaborated with international institutions and contributed to expanding dermatology services. His academic record reflects continued engagement in research and clinical innovation.[1]

Research Contributions

Major contributions include studies on atopic dermatitis, scabies prevalence, cutaneous leishmaniasis, and HIV-related skin disorders. His research has informed clinical practice and strengthened disease surveillance efforts. Several studies emphasize healthcare access and patient quality of life. These works demonstrate measurable relevance to global dermatology research.[4]

Publications

  • Impact of Atopic Dermatitis on the Quality of Life of Children in Ethiopia (2026).
  • The impact of atopic dermatitis on caregivers’ quality of life in Ethiopia (2025).
  • Atopic dermatitis in Ethiopian children: multicenter study (2024).
  • Scabies prevalence among prisoners in southern Ethiopia (2023).
  • Pattern of skin diseases in children attending dermatology clinics (2019).

Research Impact

The researcher’s publications have contributed to evidence generation in dermatology and public health. Citation metrics and international collaborations indicate growing academic influence. His work supports healthcare policy development and clinical decision-making in tropical settings. The research outputs remain relevant to practitioners and scholars worldwide.[5]

Award Suitability

The research profile demonstrates sustained productivity, international engagement, and societal relevance. Contributions to neglected tropical diseases and dermatology services illustrate measurable public health impact. These characteristics align with criteria commonly used for innovation and research awards. Recognition through the World Skincare Innovation Awards would acknowledge such achievements.

Conclusion

Abraham Getachew Kelbore has established a significant research presence in dermatology and tropical medicine. His scientific contributions address pressing healthcare challenges in Ethiopia and internationally. Continued scholarship and collaboration may further strengthen dermatological research capacity. The academic record supports professional recognition in global research forums.

External Links

References

  1. Kelbore, A. G., Enbiale, W., van Wyk, J. M., Bogino, E. A., Morrone, A., & Mosam, A. (2026). Impact of atopic dermatitis on the quality of life of children in Ethiopia: A multicenter prospective cohort study. Children. 
    https://doi.org/10.3390/children13020201
  2. Kelbore, A. G., Enbiale, W., van Wyk, J. M., & Mosam, A. (2024). Atopic dermatitis in Ethiopian children: A multicenter study of clinical severity, characteristics, and sociodemographic factors. Frontiers in Medicine. 
    https://doi.org/10.3389/fmed.2024.1410310
  3. Bogino, E. A., Beebe, N., Woldegeorgis, B. Z., Wondewosen, L., Dessu, B. K., Obsa, M. S., … & Kelbore, A. G. (2023). Scabies prevalence and its associated factors among prisoners in southern Ethiopia: An institution-based analytical cross-sectional study. PLOS Neglected Tropical Diseases. 
    https://doi.org/10.1371/journal.pntd.0011826
  4. Kelbore, A. G., Enbiale, W., Mosam, A., & van Wyk, J. M. (2022). Mapping research evidence on quality of life in children with atopic dermatitis in sub-Saharan Africa: A scoping review protocol. Systematic Reviews. 
    https://doi.org/10.1186/s13643-022-02133-w
  5. Kelbore, A. G., Owiti, P., Reid, A. J., Bogino, E. A., Wondewosen, L., & Dessu, B. K. (2019). Pattern of skin diseases in children attending a dermatology clinic in a referral hospital in Wolaita Sodo, southern Ethiopia. BMC Dermatology, 19, Article 8. 
    https://doi.org/10.1186/s12895-019-0085-5

Sophia Hatziantoniou | Encapsulation techniques for active ingredients | Excellence in Research Award

Posted on by Skincare

Dr. Sophia Hatziantoniou | Encapsulation techniques for active ingredients | Excellence in Research Award

Department of Pharmacy, University of Patras, Greece

Dr. Sophia Hatziantoniou is an accomplished pharmaceutical scientist and Associate Professor at the Department of Pharmacy, University of Patras, specializing in pharmaceutical technology, nanotechnology, topical cosmetics, and advanced drug delivery systems. Her influential investigations in liposomal formulations, nanoemulsions, dendrimer technologies, and anticancer therapeutics have earned wide scientific recognition. With an h-index of 36 and more than 4,400 citations, she has contributed significantly to pharmaceutical nanoscience and biomedical innovation. Her interdisciplinary research integrates nanomedicine, pharmaceutics, and biotechnology to develop novel therapeutic approaches with enhanced clinical effectiveness. Through impactful publications, collaborative projects, and scientific mentorship, Dr. Hatziantoniou continues advancing pharmaceutical sciences while supporting innovative healthcare solutions and translational biomedical research worldwide.

Professional Profile

Education

Dr. Sophia Hatziantoniou developed a strong academic background in pharmaceutical sciences, pharmaceutics, and nanotechnology through advanced higher education and specialized scientific training. Her educational foundation enabled extensive expertise in drug delivery systems, biomaterials, topical formulations, and cancer therapeutics. She cultivated multidisciplinary scientific skills integrating chemistry, biotechnology, pharmaceutical engineering, and biomedical sciences to support innovative healthcare applications. Her academic preparation strengthened her ability to investigate nanoformulations, liposomal carriers, and pharmaceutical nanotechnology for therapeutic improvement. Throughout her scholarly development, she demonstrated dedication to scientific excellence, evidence-based experimentation, and translational pharmaceutical research. Her educational achievements have contributed significantly to her professional growth as a respected academic researcher and mentor in pharmaceutical technology and biomedical innovation.

Professional Experience

Dr. Hatziantoniou has established an impressive professional career as an academic researcher, pharmaceutical scientist, and Associate Professor within the Department of Pharmacy at the University of Patras. She possesses extensive experience in pharmaceutical technology, nanomedicine, topical therapeutics, and anticancer drug delivery systems. Her professional activities include scientific supervision, collaborative biomedical projects, advanced pharmaceutical investigations, and mentoring emerging researchers in nanotechnology-based therapeutics. She has participated in numerous interdisciplinary studies exploring liposomes, nanoemulsions, dendrimers, and controlled-release formulations. Through continuous engagement with international scientific communities, she has contributed to the advancement of pharmaceutics and biomedical innovation. Her long-standing academic and research experience reflects exceptional dedication toward improving therapeutic technologies and healthcare-related scientific progress.

Research Interest

Dr. Sophia Hatziantoniou’s research interests primarily focus on pharmaceutical nanotechnology, advanced drug delivery systems, topical formulations, liposomal therapeutics, and cancer-targeted nanomedicine. Her investigations emphasize nanoformulations designed to improve drug bioavailability, therapeutic effectiveness, controlled release behavior, and biomedical compatibility. She actively explores lipid-based carriers, dendrimer technologies, nanoemulsions, and nanoparticle engineering for pharmaceutical and cosmetic applications. Her scientific work also examines anticancer compounds, curcumin derivatives, vaccine-related pharmaceutical safety, and biomaterial interactions within biological systems. By integrating pharmaceutical sciences with nanotechnology and biotechnology, she contributes to the development of innovative therapeutic platforms with translational healthcare significance. Her interdisciplinary research approach continues advancing pharmaceutical innovation and expanding opportunities in biomedical therapeutics and personalized medicine.

Award and Honor

Dr. Hatziantoniou has earned significant academic recognition for her impactful contributions to pharmaceutical sciences, nanotechnology, and biomedical therapeutics. Her extensive publication record, strong citation performance, and influential scientific collaborations highlight her reputation within international pharmaceutical research communities. She has contributed to highly regarded journals in pharmaceutics, nanomedicine, and biomedical engineering while participating in innovative healthcare research initiatives. Her achievements in liposomal therapeutics, topical pharmaceutical technology, and cancer nanomedicine demonstrate scientific originality and sustained academic excellence. Through collaborative investigations and advanced therapeutic studies, she has gained recognition for promoting translational pharmaceutical innovation and interdisciplinary biomedical progress. Her professional accomplishments reflect dedication to scientific discovery, mentorship, and the advancement of modern pharmaceutical technologies.

Conclusion

Dr. Sophia Hatziantoniou represents an influential figure in pharmaceutical technology and nanomedicine through her impactful scientific achievements, innovative therapeutic investigations, and interdisciplinary collaborations. Her expertise in drug delivery systems, liposomal formulations, and biomedical nanotechnology has contributed substantially to modern pharmaceutical sciences and translational healthcare innovation. With extensive scholarly influence, remarkable citation performance, and internationally recognized research contributions, she continues advancing therapeutic technologies and biomedical understanding. Her commitment to scientific excellence, mentorship, and collaborative healthcare research positions her as a distinguished academic leader with enduring influence on pharmaceutical innovation, nanotherapeutics, and future biomedical developments worldwide.

Publications Top Noted

  • Title: Nanoliposomes and their applications in food nanotechnology
    Authors: M Reza Mozafari, C Johnson, S Hatziantoniou, C Demetzos
    Year: 2008
    Citation: 938
    Citations: 701
  • Title: Metabolism and anticancer activity of the curcumin analogue, dimethoxycurcumin
    Authors: C Tamvakopoulos, K Dimas, ZD Sofianos, S Hatziantoniou, Z Han
    Year: 2007
    Citation: 238
  • Title: A DSC and Raman spectroscopy study on the effect of PAMAM dendrimer on DPPC model lipid
    Authors: K Gardikis, S Hatziantoniou, K Viras, M Wagner, C Demetzos
    Year: 2006
    Citation: 369
  • Title: lipid analysis of Greek walnut oil (Juglans regia L.)
    Authors: G Tsamouris, S Hatziantoniou, C Demetzos
    Year: 2002
    Citation: 112
  • Title: Cytotoxic and antitumor activity of liposome-incorporated sclareol against cancer cell lines and human colon cancer xenografts
    Authors: S Hatziantoniou, K Dimas, A Georgopoulos, N Sotiriadou, C Demetzos
    Year: 2006
    Citation: 94

Konstantinos avgoustakis | Natural and plant-based skincare ingredients | Research Excellence Award

Posted on by Skincare

Prof. Dr. Konstantinos avgoustakis | Natural and plant-based skincare ingredients | Research Excellence Award

University of Patras, Greece

Konstantinos Avgoustakis is a distinguished researcher recognized for his influential contributions to pharmaceutical nanotechnology, advanced drug delivery systems, and biomaterials engineering. His academic work has significantly advanced the understanding of polymeric nanoparticles, PEGylated nanocarriers, and controlled-release therapeutics for cancer treatment and biomedical applications. Through extensive interdisciplinary collaborations, he has produced highly cited publications in internationally reputed journals, reflecting his expertise in nanomedicine and pharmaceutical sciences. His research emphasizes innovative therapeutic delivery strategies that improve bioavailability, targeting efficiency, and clinical outcomes. With a strong scientific foundation and sustained scholarly productivity, Konstantinos Avgoustakis continues to inspire advancements in pharmaceutical innovation and translational biomedical research worldwide

Professional Profile

Education

Konstantinos Avgoustakis developed a strong academic foundation in pharmaceutical sciences and nanotechnology through advanced scientific training and interdisciplinary research engagement. His educational background fostered deep expertise in polymer chemistry, drug formulation technologies, biomedical engineering, and pharmaceutical innovation. Throughout his academic progression, he concentrated on nanoscale drug delivery systems and the optimization of biodegradable polymers for therapeutic applications. His scholarly preparation enabled him to bridge pharmaceutical sciences with biomedical technology, leading to impactful research in controlled drug release and targeted therapeutics. The rigorous scientific environment in which he trained cultivated analytical thinking, experimental precision, and translational research capabilities. His educational achievements laid the groundwork for his internationally recognized contributions to pharmaceutical nanotechnology and innovative healthcare solutions

Professional Experience

Konstantinos Avgoustakis possesses extensive professional experience in pharmaceutical nanotechnology, drug delivery research, and biomaterials development. Over the years, he has actively contributed to experimental and translational studies focused on nanoparticle engineering, pharmacokinetics, and therapeutic targeting strategies. His work includes the development of PLGA and PEG-based nanocarriers designed to improve the efficacy and stability of anticancer therapeutics. He has collaborated with multidisciplinary research teams, contributing to scientific innovation across pharmaceutical and biomedical disciplines. His experience also encompasses publication leadership, mentoring scientific research activities, and advancing nanoparticle-mediated therapeutic technologies. Through sustained academic productivity and impactful collaborations, he has established a respected presence within the global pharmaceutical research community while continuously supporting advancements in nanomedicine and controlled drug delivery systems

Research Interest

The primary research interests of Konstantinos Avgoustakis center on pharmaceutical nanotechnology, targeted drug delivery, polymeric nanoparticles, and advanced biomedical applications. His investigations focus on the design and optimization of biodegradable nanocarriers capable of enhancing therapeutic efficiency and reducing systemic toxicity. He is particularly interested in PLGA-based nanoparticles, PEGylated systems, anticancer formulations, pharmacokinetic modeling, and controlled-release technologies. His scientific studies explore the interaction between nanomaterials and biological systems to improve precision medicine approaches and therapeutic performance. Additionally, his work examines innovative strategies for improving bioavailability, stability, and cellular targeting of pharmaceutical compounds. Through these research directions, he contributes to the advancement of safer, more effective, and clinically adaptable nanomedicine technologies with broad applications in oncology, pharmaceutical sciences, and biomedical engineering.

Award and Honor

Konstantinos Avgoustakis has earned significant academic recognition for his pioneering research contributions in pharmaceutical nanotechnology and drug delivery sciences. His highly cited publications, strong citation metrics, and international scholarly impact demonstrate sustained excellence in biomedical and pharmaceutical innovation. He is widely acknowledged for advancing nanoparticle-mediated therapeutic systems and improving controlled drug release methodologies for cancer treatment and biomedical applications. His research achievements have enhanced scientific understanding of biodegradable polymers, targeted nanocarriers, and pharmacokinetic optimization. Through influential collaborations and impactful scientific dissemination, he has established a distinguished reputation within the pharmaceutical and nanomedicine research community. His consistent scholarly productivity and innovative scientific vision continue to position him as a respected contributor to global advancements in nanotechnology-driven healthcare and pharmaceutical engineering.

Conclusion

Konstantinos Avgoustakis represents an accomplished scientific researcher whose work has significantly influenced pharmaceutical nanotechnology and advanced drug delivery research. His extensive publication record, strong citation performance, and innovative investigations reflect a deep commitment to improving therapeutic technologies and biomedical applications. By integrating polymer science, nanomedicine, and pharmaceutical engineering, he has contributed to the development of efficient nanoparticle systems for targeted treatment strategies. His scientific contributions continue to support progress in controlled-release therapeutics, precision medicine, and biomedical innovation. Through impactful research, interdisciplinary collaboration, and sustained academic excellence, he remains an influential figure in pharmaceutical sciences. His continued dedication to scientific discovery is expected to further advance nanotechnology-based healthcare solutions and inspire future developments in global biomedical research

Publications Top Noted

  • Title: LGA–mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties
    Authors: K Avgoustakis, A Beletsi, Z Panagi, P Klepetsanis, AG Karydas
    Year: 2002
    Citations: 701
  • Title: Pegylated poly (lactide) and poly (lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery
    Authors: K Avgoustakis
    Year: 2004
    Citation: 585
  • Title: Chitosan nanoparticles loaded with dorzolamide and pramipexole
    Authors: S Papadimitriou, D Bikiaris, K Avgoustakis, E Karavas, M Georgarakis
    Year: 2008
    Citation: 369
  • Title: Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA–mPEG nanoparticles
    Authors: Z Panagi, A Beletsi, G Evangelatos, E Livaniou, DS Ithakissios
    Year: 2001
    Citation: 316
  • Title: Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA–mPEG nanoparticles
    Authors: K Avgoustakis, A Beletsi, Z Panagi, P Klepetsanis, E Livaniou
    Year: 2003
    Citation: 313

Hui Xiong | Pharmaceutics | Best Researcher Award

Posted on by Skincare

Dr. Hui Xiong | Pharmaceutics | Best Researcher Award
Associate Professor | China Pharmaceutical University | China

Dr. Hui Xiong is an Associate Professor in the Department of Pharmaceutics at China Pharmaceutical University, where she leads pioneering research in advanced drug delivery systems and nanomedicine engineering. She earned her Ph.D. in Pharmaceutics and has since focused her career on the rational design of multifunctional nanocarriers to improve the bioavailability, targeting precision, and therapeutic index of anticancer drugs. Her work integrates pharmaceutics, tumor biology, and materials science to develop innovative delivery platforms for combination therapy, pH-activated antiangiogenic chemotherapy, tumor microenvironment modulation, and ferroptosis-inducing therapeutic strategies, with a strong emphasis on breast and pancreatic cancer treatment. Dr. Xiong has published over 30 SCI papers as first or corresponding author in leading journals such as ACS Nano, Nano Letters, Journal of Controlled Release, Small, and Advanced Healthcare Materials, accumulating a total impact factor exceeding 188 and an H-index of 16. Her contributions include groundbreaking studies on vascular normalization, metabolic symbiosis-blocking nanocombinations, bioengineered nanospores for macrophage modulation, and redox-regulated nanodrugs, several of which have been featured on journal covers. She has been the principal investigator for multiple National Natural Science Foundation of China projects and holds four national invention patents, advancing translational pharmaceutics for clinical oncology. Recognized for her contributions to cancer nanomedicine, she also serves as a peer reviewer for several high-impact journals, further shaping the direction of pharmaceutics and targeted drug delivery research. 

Profile : ORCID

Publications

1. He, Z., Wang, R., Qi, Y., Liu, Y., Xiong, H.*, & Yao, J. (2024). Nanocoated bacteria with H₂S generation-triggered self-amplified photothermal and photodynamic effect for breast cancer therapy. Journal of Controlled Release.

2. Qiao, J., Liu, S., Huang, Y., Zhu, X., Xue, C., Wang, Y., Xiong, H.*, & Yao, J. (2024). Glycolysis–noncanonical glutamine dual-metabolism regulation nanodrug enhanced the phototherapy effect for pancreatic ductal adenocarcinoma treatment. Journal of Colloid and Interface Science.

3. Yao, L., Zhu, X., Shan, Y., Zhang, L., Yao, J., & Xiong, H.* (2024). Recent progress in anti-tumor nanodrugs based on tumor microenvironment redox regulation. Small.

4. Shang, Y., Lu, H., Liao, L., Li, S., Xiong, H.*, & Yao, J. (2023). Bioengineered nanospores selectively blocking LC3-associated phagocytosis in tumor-associated macrophages potentiate antitumor immunity. ACS Nano.

5. Xiong, H., Liu, X., Xie, Z., Zhu, L., Lu, H., Wang, C., & Yao, J. (2022). Metabolic symbiosis-blocking nanocombination for tumor vascular normalization treatment. Advanced Healthcare Materials.